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Background: External validation on different TBI populations is important in order to assess the generalizability of
prognostic models to different settings. We aimed to externally validate recently developed models for prediction
of six month unfavourable outcome and six month mortality.
Methods: The International Neurotrauma Research Organization – Prehospital dataset (INRO-PH) was collected
within an observational study between 2009-2012 in Austria and includes 778 patients with TBI of GCS < = 12. Three
sets of prognostic models were externally validated: the IMPACT core and extended models, CRASH basic models
and the Nijmegen models developed by Jacobs et al – all for prediction of six month unfavourable outcome and
six month mortality. The external validity of the models was assessed by discrimination (Area Under the receiver
operating characteristic Curve, AUC) and calibration (calibration statistics and plots).
Results: Median age in the validation cohort was 50 years and 44% had an admission GSC motor score of 1-3.
Six-month mortality was 27%. Mortality could better be predicted (AUCs around 0.85) than unfavourable outcome
(AUCs around 0.80). Calibration plots showed that the observed outcomes were systematically better than was
predicted for all models considered. The best performance was noted for the original Nijmegen model, but refitting
led to similar performance for the IMPACT Extended, CRASH Basic, and Nijmegen models.
Conclusions: In conclusion, all the prognostic models we validated in this study possess good discriminative ability
for prediction of six month outcome in patients with moderate or severe TBI but outcomes were systemically
better than predicted. After adjustment for this under prediction in locally adapted models, these may well be used
for recent TBI patients.
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Traumatic brain injury (TBI) is the leading cause of dis-
ability and mortality among young individuals in high-
income countries and it is a rising public health issue in
low-income countries [1]. Partly because of the hetero-
geneity of the disease in terms of cause, pathology and
severity considerable uncertainty may exist in the* Correspondence: mmajdan@igeh.org
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unless otherwise stated.expected outcome of patients [2]. Many studies reported
on univariate associations between predictors and out-
come after TBI and further research has been devoted to
combine single predictors into prognostic models [1].
Such models have a relatively wide applicability ranging
from clinical settings and research to providing informa-
tion on expectations to relatives of patients [1-3]. Facili-
tating better severity classification, stratification in the
context on Randomized Clinical Trials (RCTs) and set-
ting baseline for clinical audits could be seen as the
prime roles of prognostic models in TBI [2].Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
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for outcome of TBI which utilize a variety of predictors
and outcome measures. A systematic review published in
2006 identified 53 reports, which included a total of 102
models [4], but their quality was mostly poor [2,4].
Lack of external validation represents one of the main
shortcomings of most models. External validation on differ-
ent TBI populations, preferably collected in a multicentre
setting is important in order to assess the generalizability of
prognostic models to different settings [2,4]. It is reasonable
to expect that even though biologically the prognostic fac-
tors should be the same for all patients, the association
could differ depending on medical care received, which
may differ by place and evolve over time [4]. Specifically,
predictions based on data from decades ago may overesti-
mate the incidence of poor outcomes for current clinical
settings.
The International Mission for Prognosis and Analysis
of Clinical Trials in TBI (IMPACT) [5] and the Cortico-
steroid Randomization After Significant Head Injury
(CRASH) studies [6] are the most established prognostic
models currently. Both were developed on large patient
samples from multiple countries with state of the art
methodology and have been externally validated beyond
the process of model development [7-10]. More recently,
a set of prognostic models was developed by Jacobs et al
[11] using patient data from Nijmegen, the Netherlands.
External validation in a fully new setting has not yet been
performed (besides the external validation during develop-
ment). Further validation of these 3 sets of models in re-
cent patients is important to assess generalizability, since
differences in treatment and health care organization in
different populations have been suggested [10].
The aim of this study was to externally validate the
IMPACT, CRASH and Nijmegen models for the predic-
tion of six month unfavourable outcome and six month
mortality in a recent observational patient cohort from
Austria in 2009-2012.
Methods
Patients and population
The International Neurotrauma Research Organization
(INRO) based in Vienna aims to improve the care and
outcome of patients with TBI primarily in Austria, the
wider region of Central Europe, and in countries of the
South-Eastern European region. INRO led a prospective
observational study focusing on prehospital and early
hospital care of patients with TBI in Austria between
2009 and 2012. The study has been approved by the Ethical
Committees of all participating centres and have been per-
formed in accordance with the ethical standards laid down
in the Declaration of Helsinki and its later amendments.
All patients with Glasgow Coma Scale score (GCS) < = 12
within 48 hours after the accident and/or Abbreviatedinjury scale (AIS) [12] score of head >2 were included in
the study. Data on demographic characteristics, injury
type and severity, prehospital treatment, trauma room
treatment, surgical procedures, CT scans, Intensive Care
Unit (ICU) based treatment (first 5 days) and outcome (at
ICU discharge, hospital discharge and six month after in-
jury) were recorded. The Extended Glasgow Outcome
Scale (GOSE) was used to categorize the outcome at hos-
pital discharge (assessed by a local study investigator) and
at six months after injury (assessed by telephone interview
by a trained physician). The follow-up rate six months
after injury was 70%. We analysed data from 778 patients
from 16 centres.
Prognostic models
For this study three sets of prognostic models (eight
models in total) were selected. These models fulfilled re-
quirements for prognostic models in TBI with respect to
the study population, predictors, outcome, model develop-
ment and validation [2,3]. All models were designed to
predict six month mortality and six month unfavourable
outcome in patients with TBI. Unfavourable outcome was
defined as GOS of 1-3 (death, vegetative state or severe
disability) in all models. Table 1 presents a comparative de-
scription of models and their development characteristics.
Within the IMPACT study [13] three models of increas-
ing complexity were developed (core model, extended
model and lab model which added glucose and haemoglo-
bin levels to predictors in the extended model). We fo-
cused on the core and extended models because the lab
parameters were not available in the INRO-PH dataset.
The CRASH prognostic model [6] has two variants.
One is for patients in low and middle income countries
and the second for patients in high income countries.
For the purposes of our study the models for high in-
come countries were used. Only the basic model was
validated since the CT predictors as they were defined in
the CRASH CT models were not available in the INRO-
PH dataset. Major extra-cranial injury in the INRO-PH
dataset was defined as being serious or worse (2 or more
scoring points) according to the AIS.
The Nijmegen models [11] were developed using the
Radboud University Brain Injury Cohort Study (RUBICS)
dataset, which enrolled patients between 1999-2006 [14].
Two prognostic models were developed. In our study only
the demographic and clinical models were validated be-
cause the predictors as defined in the CT models were not
available in our validation dataset.
The IMPACT models were developed using both RCT
and observational data from a total of 11 studies, the
CRASH and Nijmegen models were developed using data
from a single study – an RCT and an observational study,
respectively. The IMPACT and CRASH datasets were
considerably larger than the dataset used to develop the
Table 1 Description of prognostic models used in the validation study and their development characteristics
Model N at
development
Development setting Data collection
period
Predictors used in model Outcome measures
IMPACT Core 8,509 8 RCTs, 3 observational studies,
multi-centre, multi-country
1984-1997 Age, GCS motor score, pupillary
reactivity
6 month mortality,
6 month unfavourable
outcome
IMPACT
extended
Core model predictors and CT
classification, hypoxia, hypotension,
tSAH, EDH
CRASH basic 10,008 RCT, multi-centre, multi-country 1999-2004 Age, GCS, pupillary reactivity,
presence of major extra-cranial injury
14 day mortality,
6 month unfavourable
outcome
Nijmegen Clinical
and demographic
700 Observational study, single centre
(Radboud University, Nijmegen,
the Netherlands)
1998-2006 Age, pupil s reactivity, GCS,
hypotension
6 month mortality,
6 month unfavourable
outcome
RCT = Randomized Clinical Trial; GCS = Glasgow Coma Scale; CT = Computed Tomography; tSAH = Traumatic Subarachnoid Haemorrhage; EDH = Epidural hematoma.
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score only) and pupillary reactivity as predictors were
common for all validated models. The Nijmegen models
used the most recent data for development.
Statistical analysis
To investigate the difference in predictor effects between
the developed models and the validation population we
fitted logistic regression models containing the predictors
of the models in the validation population (using second
level of customization). The estimated ORs of the different
predictors were compared to the ORs of the original
models. The external validity of the models was assessed
using analysis of discrimination and calibration, following
previous studies [3,7,10,13].
To assess the discrimination (ability to distinguish be-
tween survival and death or favourable and unfavourable
outcome) the area under the receiver operating charac-
teristic curve (AUC) was used. For a model with perfect
discrimination the AUC = 1.0. An AUC of 0.5 indicates
that the discriminative ability of the model is no better
than by chance. For all models AUCs at external valid-
ation (AUCVAL) were calculated along with AUCs of the
models refitted on the INRO-PH dataset (AUCREFIT).
Confidence intervals are presented for each AUCVAL cal-
culated non-parametrically, using the bootstrap method
of the ‘ci.auc’ function within the R package pROC [15].
Calibration evaluates the agreement between observed
and predicted outcomes and was assessed using validation
plots and calibration statistics (calibration-in-the-large)
[3]. In the validation plots predicted vs. observed out-
comes are plotted to depict the deviation of their agree-
ment from the optimal situation. Calibration-in-the-large
was assessed by fitting a logistic regression model with the
model predictions as an offset variable and by calculating
the intercept and calibration slope. The intercept was used
to assess whether the model predictions are systematically
too low or too high. In case of perfect calibration-in-the-
large, i.e. the percentage predicted outcome is equal to thepercentage observed, the intercept is 0. If outcomes are
better than predicted, the intercept is negative. The cali-
bration slope, which in an ideal case equals 1, was used to
quantify the average strength of the predictors, compared
to the development dataset.
Results
Comparison of datasets
The INRO-PH dataset was compared side by side with
datasets used to develop the IMPACT, CRASH and Nij-
megen models. Table 2 presents the description of pre-
dictor variables used in all models and their equivalent in
the INRO-PH dataset. Compared to the IMPACT dataset
the patients in the INRO-PH dataset were significantly
older (median of 50 vs. 30 years) with higher proportions
of EDH and tSAH, higher proportion of reactive pupils
(71% vs 63%) and similar distribution of GCS motor
scores (scores 1-3 in 44% vs. in 41% in the IMPACT data-
set). Both mortality and the proportion of unfavourable
outcome were lower in the INRO-PH dataset.
About one third of patients in the CRASH dataset had
a mild TBI whereas all patients had moderate or severe
TBI in the INRO-PH dataset. Thus, in general the sever-
ity was lower in the CRASH patients. The mean age was
higher in the INRO-PH dataset (mean 49 vs. 37 years).
The outcomes in the subset of CRASH patients with
moderate or severe TBI were worse than in the INRO-
PH patients.
The data for the RUBICS dataset (used to develop the
Nijmegen models) was reported separately for moderate
and severe TBI and where possible it was summarized.
In general, patients in the RUBICS dataset were slightly
younger and had less severe injuries (higher median of
total GCS, lower proportion of mass lesions) but had
worse outcomes compared to the INRO-PH dataset.
Predictor effects
A detailed comparison of predictor effects (using ORs) re-
ported with the original models and in the models refitted
Table 2 Characteristics of the datasets used to create the prognostic models and the INRO-PH validation dataset
Model Measure or Category INRO-PH IMPACT CRASH Nijmegen: RUBICS
Variable Moderate Severe Total
N 778 8,509 10,008 126 574 700
Age (median, IQR) Years 50 (28-69) 30 (21-45) - - -
Age (mean, SD) Years 49 (23) - 37 (17) 48 (22) 43 (20)
GCS at ED (median, IQR) Points 3 (3-8) - - 11 3
GCS at randomization
(N, %)
Mild (13-14) - - 30% - -
Moderate (9-12) - - 30% - -
Severe (3-8) - - 40% - -
Motor GCS on admission
(N, %)
None (1) 244 (31%) 1,395 (16%) - - -
Extension (2) 31 (4%) 1,042 (12%) - - -
Abnormal flexion (3) 72 (9%) 1,085 (13%) - - -
Normal flexion (4) 133 (17%) 1,940 (23%) - - -
Localizes/obeys (5/6) 218 (28%) 2,591 (30%) - - -
Untestable/missing 80 (10%) 456 (5%) - - -
Pupillary reactivity (N, %) Both pupils reactive 371 (71%) 4,486 (63%) 83% 117 (93%) 374 (65%) 491 (70%)
One pupil reactive 31 (6%) 886 (12%) 7% 6 (5%) 74 (13%) 80 (11%)
No pupil reactive 123 (23%) 1,754 (25%) 8% 3 (2%) 126 (22%) 129 (18%)
Unable to assess 8 (1%) - 3% - -
Major extracranial injury
(N, %)
Present 389 (50%) - 23% - -
Hypoxia (N, %) Yes or suspected 117 (15%) 1,116 (20%) - 12 (10%) 165 (29%) 177 (25%)
Hypotension (N, %) Yes or suspected 103 (13%) 1,171 (18%) - 7 (6%) 133 (23%) 140 (20%)
CT classification (N, %) Diffuse Injury (I) 84 (11%) 360 (7%) - 48 (40%) 104 (19%) 152 (22%)
Diffuse Injury (II) 327 (44%) 1,838 (35%) - 38 (31%) 156 (29%) 194 (28%)
Diffuse Injury (III) 55 (7%) 863 (17%) - 5 (4%) 88 (16%) 93 (13%)
Diffuse Injury (IV) 3 (1%) 187 (4%) - 0 17 (3%) 17 (2%)
Mass lesion evacuated (V) or
non-evacuated (VI)
270 (37%) 1,944 (38%) - 30 (25%) 172 (32%) 202 (29%)
tSAH Yes 437 (56%) 3,313 (45%) 32% - -
EDH Yes 128 (16%) 999 (13%) - - -
Six month outcome
(N, %)
Dead 212 (27%) 2,396 (28%) 2,146 (32%)a 29 (23%) 222 (39%) 251 (36%)
Unfavourable 265 (36%) 4,082 (48%) 3,139 (47%)a 39 (31%) 289 (50%) 328 (47%)
aFor subset of patients in the CRASH dataset with GCS < =12; GCS = Glasgow Coma Scale; tSAH = Traumatic Subarachnoid Haemorrhage; EDH = Epidural
hematoma; Data for IMPACT [13], CRASH [6] and RUBICS [11] datasets extracted from original publications-format of data presentation differs in some cases.
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as a predictor was included in all models and its effects
were similar in all comparisons. The ORs of the effect of
the summary GCS in the models and refits were identical
both in case of CRASH and Nijmegen models. The effects
if GCS motor scores 1-4 in case of the IMPACT core and
extended models were stronger in models for prediction
of unfavourable outcome; the differences were smaller in
case of mortality prediction. A generally strong effect of
none reactive pupils observed in the refitted models was
similar to values in the Nijmegen models (15.3 vs. 13.2
for mortality and 9.3 vs. 10.9 for unfavourable outcome)but differed from the values in the IMPACT and CRASH
models where this effect was smaller. Compared to the
IMPACT extended models, stronger effects of hypoxia
and Marshall CT classification were observed in the
INRO-PH dataset.
Model performance
All models showed a good ability to discriminate be-
tween survival and death and between favourable and
unfavourable outcome, as indicated by values of AUCVAL
(Table 4). In all validations, the AUC was 0.8 or higher.
In all cases higher values were achieved for prediction of
Table 3 Predictors effects on outcomes in the prognostic models and in the refitted models on INRO-PH validation dataset (Odds Ratios)
Variable Measure or Category IMPACT Core
(mortality)
IMPACT Core
(unfavourable)
IMPACT Extended
(mortality)
IMPACT Extended
(unfavourable)
Crash basic
(mortality)
Crash basic
(unfavourable)
Nijmegen DCM
(mortality)
Nijmegen DCM
(unfavourable)
M R M R M R M R M R M R M R M R
Age, years > 16 OR per year 1.04 1.05 1.04 1.04 1.03 1.04 1.03 1.04 - - - - 1.06 1.06 1.05 1.04
Age, years >40 OR per year - - - - - - - - 1.07 1.07 1.08 1.07 - - - -
GCS OR per point increase - - - - - - - - 0.8 0.8 0.8 0.8 0.9 0.9 0.9 0.9
Motor GCS None (1) 4.3 3.9 4.0 3.4 3.3 2.1 3.4 2.5 - - - - - - - -
Extension (2) 4.0 4.7 8.0 2.7 3.3 2.7 6.4 2.3 - - - - - - - -
Abnormal flexion (3) 2.2 2.2 3.5 2.1 2.1 1.7 3.3 1.5 - - - - - - - -
Normal flexion (4) 1.5 1.7 1.9 1.4 1.4 1.6 1.8 1.2 - - - - - - - -
Localizes/obeys (5/6) Ref Ref Ref Ref Ref Ref Ref Ref - - - - - - - -
Untestable / missing (9) 1.7 3.9 2.4 3.3 1.5 1.9 2.3 1.6 - - - - - - - -
Pupillary reactivity Both pupils reactive Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref Ref
One pupil reactive 1.7 1.3 1.8 1.5 1.4 1.6 1.6 1.6 3.1 1.2 2.6 1.1 1.9 1.14 1.8 1.2
No pupil reactive 3.4 15.5 3.4 8.9 2.6 10.2 2.7 5.2 5.3 12.2 3.3 7.7 13.2 15.3 10.9 9.3
Major extra-cranial injury Yes - - - - - - - 1.4 1.1 1.6 1.1 - - - -
Hypoxia Yes or suspected - - - 1.3 2.1 1.4 2.2 - - - - - - - -
Hypotension Yes or suspected - - - 2.0 2.4 1.9 2.1 - - - - 2.2 1.5 3.1 2.0
CT classification Diffuse injury (I) - - - 0.7 0.6 1.7 0.5 - - - - - - - -
Diffuse injury (II) - - - Ref Ref Ref Ref - - - - - - - -
Diffuse injury (III/IV) - - - 2.2 5.3 1.7 2.7 - - - - - - - -
Mass lesion evacuated or
non-evacuated (V/VI)
- - - 1.9 6.4 1.6 6.5 - - - - - - - -
tSAH Yes - - - 1.8 1.4 1.8 1.3 - - - - - - - -
EDH Yes - - - 0.7 0.7 0.6 0.6 - - - - - - - -
M=model; R = refitted; GCS = Glasgow Coma Scale; tSAH = Traumatic Subarachnoid Haemorrhage; EDH = Epidural Hematoma; Ref = reference category; OR = odds ratio.
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Table 4 Performance measures of the prognostic models on the INRO-PH validation dataset
Performance measures (prediction of six-month unfavourable outcome) AUC VAL (CI 95%) AUC REFIT Slope Intercept P- value*
IMPACT Core Model 0.8 (0.76-0.84) 0.82 1.073 -0.354 0.93
IMPACT Extended Model 0.81 (0.77-0.86) 0.87 1.061 -0.506 0.65
CRASH Basic Model 0.8 (0.75-0.84) 0.82 0.871 -0.505 Reference
Nijmegen Demographic and Clinical Model 0.82 (0.77-0.87) 0.83 0.865 -0.738 0.47
Performance measures (prediction of six-month mortality) AUC VAL AUC REFIT Slope Intercept P- value*
IMPACT Core Model 0.84 (0.8-0.87) 0.86 1.381 -0.211 0.55
IMPACT Extended Model 0.85 (0.81-0.89) 0.9 1.323 -0.243 0.32
CRASH Basic Model 0.82 (0.77-0.87) 0.85 0.866 0.207 Reference
Nijmegen Demographic and Clinical Model 0.86 (0.82-0.91) 0.87 0.984 -0.289 0.19
AUC VAL = Area under the curve of external validation; AUC REFIT = Area under the curve of the refitted models; CI = Confidence Interval.
*P value refers to difference between AUC VAL: The model with the lowest AUCVAL was taken as a reference and tested with all other AUCVAL.
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Nijmegen models showed the best discriminative ability
for both outcomes, the difference in AUCVAL compared
to other models were small (0.01-0.02 points in case of
unfavourable outcome and 0.01-0.04 in case of mortality)
and non-significant.
The difference between AUCVAL and AUCREFIT reflected
the extent to which the effects of predictors in the original
models were suboptimal. The AUCREFIT shows the max-
imum discrimination achievable using the INRO-PH data-
set, given the specification of predictors in each of the
original models. For all models, the performance was bet-
ter after refitting, with AUCs of 0.82 or higher.
The calibration plots (Figures 1 and 2) indicate system-
atic under prediction in all cases and a better calibration
of models for prediction of mortality compared to the
models for prediction of unfavourable outcome. Except
for the CRASH mortality model (intercept 0.207), all ob-
served frequencies of unfavourable outcome and death
were better than predicted (intercept <0). Calibration
slopes were close to 1 in all cases (0.865-1.073 in case of
unfavourable outcome and 0.866-1.381 in case of models
for prediction of mortality), indicating good calibration.
The IMPACT extended model had the slope closest to
1 (1.061) for prediction of unfavourable outcome and for
mortality prediction the slope of the Nijmegen model was
closest to 1 (0.984).
Discussion
We conducted a study to externally validate three sets of
prognostic models for prediction of outcome in patients
with moderate or severe TBI using a recently (2009-
2012) collected observational dataset of 778 TBI patients
from Austria. We focused on recently developed models
that fulfilled high methodological standards for their de-
velopment. We confirmed the external validity of the
IMPACT and CRASH models in predicting outcome of
patients with moderate or severe TBI in the INRO-PHdatabase of Austrian TBI patients. In addition, our re-
sults showed good performance of the more recently de-
veloped Nijmegen models. The overall performance of
all models in cross-comparison was similar as indicated
by calibration and discrimination measures.
All models were externally validated before as part of
their development. The IMPACT models were externally
validated on a set of 6,681 patients from the CRASH
trial; CRASH models have been externally validated using
the IMPACT dataset; and the Prospective Observational
Cohort Neurotrauma [16] dataset was used to validate the
Nijmegen models.
The IMPACT core and CRASH basic models were
additionally externally validated side by side using 5
different datasets (3 RCTs and 2 observational studies)
[10]. Furthermore, both the IMPACT core and extended
models were validated using the Prospective Observa-
tional Cohort Neurotrauma [16] dataset of 415 cases [7]
and using a dataset of 587 patients with prospective con-
secutive data collection [8]. All three studies concluded
that the models performed well on the validation data-
sets. Another study validated the IMPACT models on a
set of 342 patients from a retrospective single centre
study and also confirmed their good performance [9].
Our findings contribute further to the evidence base on
the performance of prognostic models for TBI patients.
Specifically, we observed a better than expected outcome
in recent patients. We note however that caution must be
used when interpreting our findings because factors be-
yond the model and its development must be considered.
First, the discrimination of the model on external datasets
is highly sensitive to case-mix of patients - substantially
higher AUCs were reported when using observational data-
set compared to RCTs due to generally less restricted pa-
tient enrolment criteria [10].
Second, the calibration of the models is influenced by
the effect of predictors and by the distribution of out-
comes. A previous study reported that miscalibration
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Figure 1 Calibration plots for prognostic models predicting 6 month mortality. In the figures predicted probabilities of mortality or
unfavourable outcome are plotted against actual observed proportions and this relationship is shown as a curve. The dotted diagonal line shows
the optimal shape of the curve where the predicted and observed values match. The triangles show observed proportions by decile of predicted
probability.
Majdan et al. Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2014, 22:68 Page 7 of 10
http://www.sjtrem.com/content/22/1/68could occur due to differences in outcome of patients on
the GOS scale. This was found to be U-shaped in the
IMPACT and CRASH development datasets (e.g. relatively
many patients died or had favourable outcome, and rela-
tively few patients were vegetative or had severe disability)
and differed from the distribution in their validation datasets
[10]. In our patients, the distribution of outcomes was simi-
larly U-shaped as in the IMPACT and CRASH studies. We
can therefore assume that in our study the miscalibrationwas at least to some extent influenced by the different pre-
dictor effects (see Table 3 for details).
Third, additional factors that influence the overall per-
formance of the models include system factors such as
trauma care organization or treatment policies. We can
speculate that the advances in treatment could be the
cause of better than predicted outcomes, although there
is no clear evidence to support this presumption [17,18].
A number of specific factors could be relevant here:
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Figure 2 Calibration plots for prognostic models predicting 6 month unfavourable outcome.
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http://www.sjtrem.com/content/22/1/68A) patients in the INRO-PH dataset were treated by
well-trained emergency physicians in the field, and the
mean interval between arrival of Emergency Medical
Service teams and arrival at hospital was only 51 minutes;
B) the short intervals between hospital admission and
first CT scan (median of 25 minutes), and between CT
scan and surgery (median between ER admission and
surgery was 93 minutes); and C) a high proportion of pa-
tients had advanced management of possible coagulation
disorders [19].Influences of case-mix of patients, predictor effects, out-
come distribution and improvements of care could be tack-
led by adjusting the models [20].
Nevertheless, our study and previous evidence [7-10,13]
suggests that the IMPACT, CRASH and Nijmegen models
are valid and useful tools that can be effectively used
for predicting the risk of adverse outcome in patients
with TBI. Such prediction is relevant in clinical settings as
well as research where quantification of expected out-
comes of patients can be helpful in assessing quality of
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http://www.sjtrem.com/content/22/1/68care and evaluating the effectiveness of certain procedures
(e.g. by comparing expected vs. observed outcome). Fur-
thermore, they could be used to inform relatives of
patients, to make treatment decisions or to decide on
allocation of resources [7].
From the practical point of view, two aspects could be
considered when deciding on the model to be used. First,
the complexity of the model. In general, more complex
models (e.g. those including clinical variables such as CT
scan findings) have better discriminative ability [7,10].
However, in our study the performance of more complex
models (IMPACT extended models) was not much better
than that of simpler models. In fact, the IMPACT core
model, the simplest model validated in this study which
uses only three predictors, performed similarly to all other
models. Another dimension to this aspect of a model is
that the more predictors are needed the higher chance
that some will be missing - making predictions impossible.
Thus, models with less predictors could be preferred over
more complex models as we can assume that the informa-
tion for the prediction will be easier to obtain and such
models perform similarly to more complex models. Sec-
ond, the actual usability of the model is tested by external
validation studies using various populations, such as in our
study. Therefore, more external validations could mean
higher confidence in the performance of the model.
In our study the Nijmegen models performed best (al-
though the differences compared to other models were
small). However, in the time of writing this paper these
models were not externally validated as widely as the
IMPACT or CRASH models and thus recommending
their preference over other models should be cautious.
The fact that a number of different prognostic models
for prediction of outcome in patients with TBI are avail-
able with different sets of predictors and outcomes used
provides clinicians and researchers with a range of
choices. The decision on which model to use in specific
settings and situations could be made according to the
above mentioned factors and will be in most situations
driven by availability of predictor values and/or the de-
sired outcome to be predicted. In order to maintain and
extend the range of available models it is of cardinal im-
portance that the models will be continuously validated
in external settings and updated using more recent data.
We acknowledge that this study has some limitations.
Some measures and variables may not exactly match
with the development data. For example, some measures
differ as to the timing of their assessment (e.g. GCS at
randomization in the CRASH dataset is compared to
GCS at trauma room in the INRO-PH dataset). Further-
more, there might be other differences such as method-
ology of assessment of six month outcome, which tends
to differ between studies, related to outcome distribution
and predictor effects [10].In the CRASH model a relatively loose definition of
MEI is used: “an injury requiring hospital admission
within its own right” [21]. Such a broad definition may
include various types of injuries in various settings. In our
study we defined MEI as any injury with an AIS > 2 and
thus the actual injuries considered as MEI in CRASH and
in our study may differ.
The findings of this study should not be generalized
without cautious considerations. Prognostic models should
be seen as tools to predict outcomes in clusters of patients
with certain characteristics and may thus aid clinical, re-
search and policy work. The findings of this study inherit
these characteristics and they should be interpreted and
used in such context.
In conclusion, all the prognostic models we validated in
this study possess good discriminative ability for prediction
of six month outcome in patients with moderate or severe
TBI but outcomes were systemically better than predicted.
After adjustment for this under prediction in locally adapted
models, these may well be used for recent TBI patients.
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